^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Ventana MMR RxDx Panel

    Company:
    Roche
    Type:
    FDA Approved
    Related tests:
    2years
    JUST IN: @US_FDA approved pembrolizumab for microsatellite instability-high (MSI-H)/ mismatch repair deficient (dMMR) patients with advanced endometrial carcinoma after prior systemic therapy FDA also approved VENTANA MMR RxDx Panel @OncoAlert @OncLive https://t.co/SId3CpgVwe ()
    FDA event • Clinical • Mismatch repair
    |
    MSI (Microsatellite instability)
    |
    MSI-H/dMMR
    |
    Ventana MMR RxDx Panel
    |
    Keytruda (pembrolizumab)
    over2years
    Is it #TweetorialTuesday yet?! Join us tomorrow as we continue our focus on the new VENTANA MMR RxDx Panel. Catch the Twitter thread here tomorrow at noon! #IHCPath #RocheMSA #endometrialcarcinoma #mismatchrepair #chromosomalinstability (@RocheDiaUSA)
    Mismatch repair
    |
    Ventana MMR RxDx Panel
    over2years
    Welcome to another edition of #TweetorialTuesday! This week we continue our focus on the new VENTANA MMR RxDx Panel. Let's get started! #IHCPath #RocheMSA #endometrialcarcinoma #mismatchrepair #chromosomalinstability (@RocheDiaUSA)
    Mismatch repair
    |
    Ventana MMR RxDx Panel
    almost3years
    Get ready for another #TweetorialTuesday! This month we will focus on the new VENTANA MMR RxDx Panel. Catch the Twitter thread today at noon! #IHCPath #RocheMSA #endometrialcarcinoma #mismatchrepair #chromosomalinstability (@RocheDiaUSA)
    Mismatch repair
    |
    Ventana MMR RxDx Panel